Recent Price Movement and Market Context
On the day of the new low, GPT Healthcare Ltd’s stock fell by 3.51%, underperforming the Sensex’s 2.92% decline. Despite outperforming its hospital sector by 2.33% on the same day, the stock’s overall trend remains negative. After two consecutive days of gains, the price reversed sharply, closing below key moving averages including the 20-day, 50-day, 100-day, and 200-day marks, though it remained above the 5-day average. The hospital and healthcare services sector itself declined by 2.31%, indicating broader sectoral weakness.
Over longer periods, the stock’s performance has been notably subdued. It has lost 13.76% year-to-date compared to the Sensex’s 10.10% decline. Over one year, GPT Healthcare Ltd’s shares have fallen 10.90%, while the Sensex gained 3.07%. The three-month and one-month returns stand at -12.23% and -6.17% respectively, both lagging behind the Sensex’s -9.51% and -8.86%. The stock has also failed to generate any returns over three and five years, contrasting sharply with the Sensex’s 28.10% and 50.15% gains over the same periods. The ten-year return remains flat at 0.00%, while the Sensex surged 209.00%.
Financial Performance and Profitability Metrics
GPT Healthcare Ltd’s financial results have been under pressure, with the company reporting negative earnings for three consecutive quarters. Operating profit has contracted at an annualised rate of -10.80% over the past five years, signalling challenges in sustaining growth. The company’s interest expense has increased significantly, rising by 66.79% to Rs.4.42 crores in the latest six-month period, which has impacted profitability.
The operating profit to interest coverage ratio has deteriorated to a low of 9.16 times, indicating reduced buffer to service debt costs. Return on capital employed (ROCE) for the half-year period stands at 18.76%, which, while positive, is the lowest recorded in recent assessments. Despite this, management efficiency remains relatively strong, with a higher ROCE of 25.62% noted in other evaluations.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Valuation and Debt Position
The company maintains a low debt-to-EBITDA ratio of 0.53 times, reflecting a conservative leverage profile and a strong ability to meet debt obligations. Its enterprise value to capital employed ratio stands at 3.4, which is considered very attractive and suggests the stock is trading at a discount relative to its peers’ historical valuations.
However, despite this valuation appeal, the stock’s profitability has declined, with profits falling by 18.7% over the past year. This decline in earnings has contributed to the stock’s underperformance relative to the BSE500 index over one year, three months, and three years.
Institutional Investor Activity
Institutional investors have reduced their holdings by 0.72% in the previous quarter, now collectively holding 8.94% of the company’s shares. This reduction in institutional participation may reflect a reassessment of the company’s fundamentals by investors with greater analytical resources.
Comparative Performance and Market Sentiment
GPT Healthcare Ltd’s Mojo Score currently stands at 36.0, with a Mojo Grade of Sell, downgraded from Hold as of 30 Sep 2025. The company’s market capitalisation grade is rated 4, indicating a relatively modest market cap within its sector. The downgrade in grading aligns with the stock’s sustained negative returns and deteriorating financial metrics.
Why settle for GPT Healthcare Ltd? SwitchER evaluates this Hospital micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Summary of Key Financial Indicators
Over the last five years, GPT Healthcare Ltd’s operating profit has declined at an annualised rate of -10.80%. The company has reported negative earnings for three consecutive quarters, with interest expenses rising sharply by 66.79% to Rs.4.42 crores in the latest half-year. The operating profit to interest coverage ratio has fallen to 9.16 times, while ROCE for the half-year is at 18.76%, the lowest in recent periods.
Institutional investors have trimmed their stake by 0.72% in the previous quarter, now holding 8.94%. The stock’s Mojo Grade was downgraded from Hold to Sell on 30 Sep 2025, reflecting the deteriorating fundamentals and subdued market performance.
Despite a low debt-to-EBITDA ratio of 0.53 times and a favourable enterprise value to capital employed ratio of 3.4, the stock has underperformed the broader market and its sector peers consistently. Profitability has declined by 18.7% over the past year, and the stock has generated negative returns over one, three, and five-year periods.
Conclusion
GPT Healthcare Ltd’s stock reaching an all-time low of Rs.118.2 underscores the ongoing challenges faced by the company in maintaining growth and profitability. The combination of declining earnings, increased interest costs, reduced institutional participation, and a downgraded Mojo Grade paints a picture of a stock under sustained pressure. While valuation metrics suggest the stock trades at a discount relative to peers, the financial performance and market sentiment remain subdued as of 9 Mar 2026.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
